Aquestive Therapeutics Inc (AQST)
3.52
+0.24
(+7.32%)
USD |
NASDAQ |
May 03, 16:00
3.54
+0.02
(+0.57%)
After-Hours: 06:25
Aquestive Therapeutics Shareholders Equity (Quarterly): -106.49M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -106.49M |
September 30, 2023 | -102.93M |
June 30, 2023 | -106.65M |
March 31, 2023 | -109.24M |
December 31, 2022 | -118.55M |
September 30, 2022 | -107.82M |
June 30, 2022 | -96.36M |
March 31, 2022 | -93.14M |
December 31, 2021 | -82.13M |
September 30, 2021 | -60.34M |
June 30, 2021 | -53.77M |
March 31, 2021 | -51.80M |
December 31, 2020 | -48.50M |
Date | Value |
---|---|
September 30, 2020 | -36.52M |
June 30, 2020 | -21.39M |
March 31, 2020 | -20.83M |
December 31, 2019 | -6.122M |
September 30, 2019 | -34.46M |
June 30, 2019 | -24.66M |
March 31, 2019 | -6.056M |
December 31, 2018 | 10.08M |
September 30, 2018 | 23.44M |
June 30, 2018 | -38.95M |
March 31, 2018 | -22.82M |
December 31, 2017 | -26.50M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-118.55M
Minimum
Dec 2022
-6.122M
Maximum
Dec 2019
-67.46M
Average
-60.34M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
Lifecore Biomedical Inc | -1.842M |
Harrow Inc | 70.77M |
Akebia Therapeutics Inc | -30.58M |
89bio Inc | 536.31M |
Geron Corp | 344.87M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 57.42M |
Total Liabilities (Quarterly) | 163.90M |
Debt to Equity Ratio | -0.2585 |
Current Ratio | 2.238 |
Net Debt Paydown Yield | 3.67% |